NCT03906825

Effect of CEAG on Inflammation and Endothelial Function

Acute Effects of Curcuminoids, EPA (Omega-3), Astaxanthin and GLA (CEAG) on Inflammation and Endothelial Function

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to look at the effect a dietary supplement called CEAG \[Curcuminoids, EPA (Omega-3), Astaxanthin and Gamma Linolenic Acid (GLA)\] has on inflammation and endothelial (inner layer of the blood vessels) function and whether it causes a lowering of blood pressure.The endothelium plays in an important role in blood pressure.

Detailed description

This clinical trial is to assess the efficacy of Curcuminoids, EPA (Omega-3), Astaxanthin and GLA for improving inflammation and endothelial reactivity over a four week intervention period in individuals with metabolic syndrome. The study also examines the effect of Curcuminoids, EPA (Omega-3), Astaxanthin and GLA administration on other markers of cardiovascular function and cardiovascular disease risk including Total, LDL and HDL-Cholesterol, Triglycerides, and a multitude of inflammatory markers.

Conditions

• Inflammation
• Endothelial Dysfunction

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	CEAG	Curcuminoids, EPA (OMEGA-3), Astaxanthin, GLA
DIETARY_SUPPLEMENT	placebo	placebo

Timeline

• Start date: 2018-05-17
• Primary completion: 2018-08-13
• Completion: 2018-08-13
• First posted: 2019-04-08
• Last updated: 2020-04-09

Locations

1 site across 1 country: United States